Quick Answer
Wave Life Sciences Ltd. reported Net Income Loss of -$204.38 million for the year ending 2025.
- Wave Life Sciences Ltd. showed a decrease of -110.7% in Net Income Loss from 2024 to 2025.
- This data is from Wave Life Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2013 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2015: -$3.70 million | Q3 2015: -$4.94 million | Q4 2015: -$7.10 million | Q1 2016: -$7.85 million | Q2 2016: -$11.57 million | Q3 2016: -$17.54 million | Q4 2016: -$18.45 million | Q1 2017: -$21.10 million | Q2 2017: -$24.60 million | Q3 2017: -$25.49 million | Q4 2017: -$30.79 million | Q1 2018: -$35.24 million | Q2 2018: -$35.89 million | Q3 2018: -$37.63 million | Q4 2018: -$37.89 million | Q1 2019: -$44.20 million | Q2 2019: -$41.94 million | Q3 2019: -$50.73 million | Q4 2019: -$56.77 million | Q1 2020: -$47.49 million | Q2 2020: -$40.53 million | Q3 2020: -$33.10 million | Q1 2021: -$42.46 million | Q2 2021: -$38.77 million | Q3 2021: -$6.23 million | Q1 2022: -$37.81 million | Q2 2022: -$41.30 million | Q3 2022: -$39.00 million | Q1 2023: -$27.41 million | Q2 2023: -$21.10 million | Q3 2023: $7.25 million | Q1 2024: -$31.56 million | Q2 2024: -$32.92 million | Q3 2024: -$61.78 million | Q1 2025: -$46.88 million | Q2 2025: -$50.47 million | Q3 2025: -$53.85 million.
- Over the full 13 years of available data (2013 to 2025), Wave Life Sciences Ltd.'s Net Income Loss has declined by 6,059.7%.
- Historical annual values: Fiscal year 2025: -$204.38 million | Fiscal year 2024: -$97.01 million | Fiscal year 2023: -$57.51 million | Fiscal year 2022: -$161.82 million | Fiscal year 2021: -$122.25 million | Fiscal year 2020: -$149.91 million | Fiscal year 2019: -$193.64 million | Fiscal year 2018: -$146.65 million | Fiscal year 2017: -$101.98 million | Fiscal year 2016: -$55.66 million | Fiscal year 2015: -$19.20 million | Fiscal year 2014: -$5.23 million | Fiscal year 2013: -$3.32 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: